Minimization in crossover trials with non-prognostic strata: theory and practical application

Area of Science:

• Clinical Trials
• Biostatistics
• Medical Research Methodology

Background:

• Ensuring comparable treatment groups is crucial for valid clinical trial analysis.
• Traditional randomization may fail in small trials, necessitating advanced allocation methods.
• Balancing prognostic factors before analysis is preferable to post-hoc adjustments.

Purpose of the Study:

• To evaluate the utility of minimization for achieving group balance in clinical trials.
• To address concerns regarding the use of conventional analysis following minimization.
• To demonstrate minimization's effectiveness in complex trial designs, such as crossover trials.

Main Methods:

• Minimization, a deterministic allocation technique, was employed to balance prognostic factors.
• The method was applied in two randomized crossover trials.
• Balance was sought not only for randomized treatments but also for differential trial procedures.

Main Results:

• Minimization successfully achieved balance between groups based on prognostic factors and differential trial procedures.
• Theoretical concerns associated with minimization in other contexts were not applicable here.
• The technique proved valuable for ensuring comparability in the described crossover trials.

Conclusions:

• Minimization is an effective allocation strategy for clinical trials, particularly when balancing multiple factors is desired.
• Its application in crossover trials with differential procedures is advantageous.
• Minimization facilitates the generation of comparable groups, supporting robust clinical trial analysis.